This guide walks through each test on a thyroid panel, what high and low results may reflect, what can distort them, which markers are worth running alongside, and when to speak to a clinician. It is educational content and not medical advice.
TSH is the pituitary gland's instruction to the thyroid, and it is ordered first because it moves earliest and furthest when thyroid hormone output changes. The pituitary samples circulating thyroid hormone continuously and pushes TSH up when hormone is scarce, down when it is plentiful. That inverse relationship is the reason an overactive thyroid usually shows as a low or unmeasurable TSH rather than a high one.
A TSH value on its own is a signal, not an answer. It tells you the pituitary is reacting to something, without telling you what. The dedicated TSH page covers what the marker is, how it is measured, how its ranges are set and how to read a single result. Everything below stays on the specific question of the pattern that points toward Graves disease.
Graves disease is an autoimmune condition in which antibodies bind to the TSH receptor on thyroid cells and activate it, so the gland produces and releases hormone without waiting for a pituitary signal 1. That single mechanism explains almost everything a thyroid panel shows. The thyroid is being driven from outside the normal feedback loop, so free T4 and free T3 climb. The pituitary sees the excess and shuts its own output down, so TSH falls toward the floor of the assay. The antibody that starts the process is itself measurable, which is what makes this condition unusually well defined in the laboratory.
Graves disease is the most common cause of an overactive thyroid 2. Research suggests that it arises when inherited susceptibility meets environmental contributors such as smoking, iodine exposure and stressful life events, and that it occurs more often in women than in men 3.
The practical consequence for testing is that no single number settles the question. Diagnosis rests on the biochemical picture of thyroid overactivity combined with evidence that the TSH receptor is being stimulated by antibodies, interpreted alongside the clinical examination 5. A reader looking at one line on a lab report is seeing one frame of a sequence, and the sequence is what a clinician reads.
A panel used to investigate suspected Graves disease normally combines a pituitary marker, the thyroid hormones themselves, and antibody testing. Each one answers a different question, and the answers only make sense stacked together.
| Test | What it measures | What it adds to the picture |
|---|---|---|
| TSH | The pituitary signal telling the thyroid how much hormone to make | The most sensitive early indicator that hormone output has shifted |
| Free T4 | Unbound thyroxine circulating and available to tissues | Shows whether the thyroid is genuinely overproducing hormone |
| Free T3 | Unbound triiodothyronine, the more biologically active hormone | Can be raised when free T4 is still within range |
| Total T3 | T3 bound to carrier proteins plus free T3 | Used by some labs where a free T3 assay is not offered |
| TSH receptor antibodies (TRAb) | Antibodies directed at the TSH receptor | Points to an autoimmune, receptor-driven cause rather than another one |
| Thyroid stimulating immunoglobulin (TSI) | The stimulating subset of those antibodies, measured by a bioassay | Distinguishes stimulating antibody activity specifically |
| Thyroid peroxidase antibodies (TPO) | Antibodies against a thyroid enzyme | Supports an autoimmune picture in general, not Graves disease specifically |
Not every panel includes every row. Many clinicians start with TSH, add free T4 and free T3 when TSH is suppressed, then add antibody testing once the hormone pattern is confirmed. Guidance on diagnosis describes exactly this staged approach, with the biochemical confirmation of overactivity coming before the search for its cause 6.
Reference ranges describe where most results from a reference population fall, and they are set by the individual laboratory running the assay. Two labs can report the same blood sample against different numbers, which is why the units and the lab's own range printed beside your result always take priority over any range you read online.
| Marker | Typical lab reference range | FitScript optimal range |
|---|---|---|
| TSH | 0.45 to 4.5 mIU/L | 0.5 to 2 mIU/L |
| Free T4 | Roughly 0.8 to 1.8 ng/dL | No optimal range published |
| Free T3 | Roughly 2.3 to 4.2 pg/mL | No optimal range published |
| TSH receptor antibodies | Assay specific cut-off reported by the lab | No optimal range published |
| Thyroid peroxidase antibodies | Assay specific cut-off reported by the lab | No optimal range published |
These are typical lab reference ranges, and they vary by laboratory, assay, age and sex. Optimal ranges are FitScript's optimization targets, not diagnostic cut-offs, and a result outside an optimal range is a prompt for a conversation rather than a finding in itself.
Antibody results deserve a note of their own. They are reported against an assay specific threshold rather than a population range, usually as positive, negative or borderline with a numeric value attached. A borderline antibody result is genuinely ambiguous and is read in light of the hormone pattern, not on its own.
A suppressed TSH alongside a raised free T4, a raised free T3, or both, is the biochemical signature of an overactive thyroid, and it is the pattern that triggers a search for the cause 6. Taking the three steps in order makes it easier to read.
The observation is straightforward. TSH sits below the lower limit, often close to undetectable, while one or both of the free hormones sit above the upper limit. The pituitary has reduced its signal as far as it can, and the thyroid has carried on regardless.
What it may reflect is a thyroid that is no longer taking instruction. In Graves disease that happens because the receptor is being stimulated by antibodies 1, but the same hormone pattern can appear with an inflamed thyroid leaking stored hormone, with an autonomously functioning nodule, or with an external source of thyroid hormone. The hormone numbers describe the state. They do not name the mechanism.
The next step is a conversation. A clearly suppressed TSH with raised free hormones is worth discussing with a clinician promptly, because the cause changes what happens next and because the pattern can persist quietly for a long time before anyone notices. Any treatment decision that follows belongs to a licensed provider who has examined you and read the full result set.
TSH receptor antibodies identify the mechanism, which is the part hormone levels cannot reveal. Two people can have an identical suppressed TSH and an identical raised free T4 for entirely different reasons, and the antibody result is usually what separates them.
There are two laboratory approaches in common use. A TRAb assay detects antibodies that bind the TSH receptor, whether they stimulate it, block it, or neither. A TSI bioassay goes a step further and measures stimulating activity specifically, which is the activity that drives the thyroid in Graves disease. A systematic review and meta-analysis comparing the two found that both perform strongly for identifying Graves disease, with evidence suggesting the stimulating-activity assay offers particularly high specificity 7. Which assay appears on your report depends on what your laboratory offers.
A positive antibody result in the context of a suppressed TSH and raised free hormones makes a receptor-driven cause considerably more likely. A negative result does not automatically close the question, since assay sensitivity differs and the clinical picture still carries weight. This is precisely why antibody values are reported with the hormone values rather than instead of them, and why a clinician reads them together rather than one at a time.
Thyroid peroxidase antibodies sometimes appear on the same report. They indicate autoimmune activity directed at the thyroid in general and can be positive in several autoimmune thyroid conditions, so they support the broader picture without pinning down the cause.
A low TSH with normal free T4 and free T3 is the subclinical pattern, and it means the pituitary has detected more thyroid hormone activity than it wants while the hormones themselves still sit inside the reference range. It is a common finding and it does not carry a diagnosis with it.
Several things can produce it. Mild thyroid overactivity in its early stage is one. A recovering episode of thyroid inflammation is another, because TSH can stay suppressed for a period after hormone levels normalise. Transient suppression during or after a significant illness also happens. Some medicines can influence thyroid results as well, so it is worth asking your prescriber whether anything you take is relevant rather than assuming it is not.
The standard response to this pattern is a repeat test rather than a conclusion, because a single low TSH tells you less than two readings separated by time. Repeat timing and any further testing are decisions for a clinician who knows the rest of your history.
Plenty can, and knowing the list prevents a lot of unnecessary alarm. Thyroid assays are sensitive, and sensitivity cuts both ways.
Acute illness is the most common confounder. Serious infection, surgery, injury and hospital admission all shift thyroid results in patterns that have nothing to do with thyroid disease, and the sensible move is to retest once recovery is complete rather than interpret a sick-day panel. Recovery from a period of thyroid inflammation produces its own temporary pattern.
Supplements and medicines matter too. Some supplements interfere with the immunoassay chemistry that laboratories use, producing results that are wrong rather than merely unexpected, and some medicines genuinely change thyroid hormone handling. Bring a full list of everything you take to the appointment and ask your prescriber directly rather than guessing.
Then there are the mundane sources of variation. TSH follows a daily rhythm and tends to read higher in the early hours and lower later in the day, so two values drawn at different times are not strictly comparable. Different laboratories use different assays and different reference ranges, so switching labs mid-investigation introduces noise into a trend. Stress is a frequent question here, and while research suggests that stressful life events sit among the environmental contributors to Graves disease 3, stress alone does not explain a clearly abnormal set of thyroid results.
It is a standard venous blood draw, usually from the arm, and all of the markers above can come from the same collection. There is no separate procedure for antibody testing and no preparation beyond what the rest of the panel requires.
Fasting is generally not required for thyroid markers themselves. If the thyroid tests are bundled into a wider panel that includes glucose, insulin or a lipid profile, follow the fasting instruction given for those, because the broader panel sets the rule. Where a morning appointment is practical, taking it consistently is useful, since comparing like with like over time is more informative than comparing a morning value with an afternoon one.
Two habits improve the quality of what you get back. The first is using the same laboratory for repeat testing where you can, so that assay differences do not masquerade as biological change. The second is recording what was happening around the draw, including recent illness, poor sleep, an unusually hard training block, or any new supplement, because context changes interpretation.
Comprehensive testing also puts thyroid markers in company. A membership like FitScript tests 150+ biomarkers per year and has Atlas, its AI health advisor, interpret each result against the rest of the picture, which is closer to how a clinician reads a panel than reading one line at a time.
The markers worth adding are the ones that describe the downstream effects of thyroid overactivity and the company the condition tends to keep. None of them diagnose anything by themselves.
A complete blood count and a comprehensive metabolic panel give a baseline for liver markers, calcium and kidney function, all of which can shift when metabolic rate changes. Lipids often move in the setting of altered thyroid status, which is one reason a cholesterol result taken during an untested thyroid problem can be misleading. Markers of iron status, vitamin D and vitamin B12 are reasonable additions because deficiency symptoms overlap heavily with thyroid symptoms, and fatigue attributed to one can belong to the other.
Autoimmune company is the other reason to test more broadly. Graves disease is associated with other autoimmune conditions, which is part of why clinicians often look beyond the thyroid when one autoimmune diagnosis is established 5. Glucose and HbA1c are commonly included for that reason and because metabolic rate affects them.
Finally, the cardiovascular and skeletal consequences deserve attention rather than markers alone. Sustained thyroid overactivity is associated with atrial fibrillation and reduced bone density 2, so a clinician may add a pulse check, a rhythm assessment or bone density evaluation to the plan depending on age and history. Which additions apply to you is a clinical judgement, not a checklist.
When the antibody result and the hormone pattern do not line up neatly, imaging usually comes next. The question being asked is mechanical rather than immunological. Is the whole gland overactive, is one area overactive, or is stored hormone leaking out of an inflamed gland that is not overproducing at all?
Thyroid ultrasound, including assessment of blood flow, and nuclear uptake imaging are the usual tools, and they are selected according to the clinical picture and local availability 6. Imaging is also useful where a nodule is felt on examination or seen incidentally, since a nodule changes what the clinician needs to rule out. Current management guidance describes a sequence that moves from biochemistry to antibodies to imaging when the first two steps leave a question open 8.
None of this is something to arrange yourself off the back of a lab report. The reason imaging follows antibodies rather than preceding them is that in most cases the antibody result resolves the question without further testing. Where it does not, the clinician who ordered the labs decides what comes next and why.
Eye involvement is part of the same autoimmune process, which is why it is relevant to a panel that otherwise measures only blood. Thyroid eye disease affects a subset of people with Graves disease, and it can appear before, alongside, or after thyroid dysfunction becomes apparent in the blood 9. That timing is the key point. Normal looking eyes do not rule out the condition, and eye changes do not require abnormal labs on the same day.
The symptoms are described in plain terms. Grittiness, watering, light sensitivity, a feeling of pressure behind the eyes, puffiness of the lids, a staring or widened appearance, double vision, or any change in vision itself. Smoking is associated with thyroid eye disease, which makes it one of the few modifiable factors in the picture 9. Current guidance treats the eye and the thyroid as two parts of one condition that are assessed and followed together 8.
For someone looking at lab results, the practical takeaway is to report eye symptoms explicitly rather than waiting to be asked. Any change in vision, new double vision, or significant eye pain is worth contacting a clinician about promptly rather than at the next scheduled appointment.
The retest interval is set by the clinician, because it depends on how abnormal the results were, whether symptoms are present, and what has already been ruled in or out. There is no universal number of weeks that applies to everyone, and inventing one here would be worse than useless.
What is general is the principle. Borderline or isolated abnormalities are usually repeated before anything is concluded, since single values drift and assays vary. A clearly abnormal pattern tends to be followed more closely than a marginal one. Once a cause has been established and a clinician is managing it, monitoring intervals are set by that clinician and typically change over time as results stabilise.
Two practical points improve the value of repeat testing. Keep the laboratory and the approximate time of day consistent, so you are measuring biology rather than methodology. Keep your own record of results with dates, because a trend across three timepoints carries far more information than one result in isolation, and clinicians rarely have every historical value in front of them.
Any clearly suppressed TSH with raised free T4 or free T3 is worth discussing with a clinician promptly.
Some situations deserve same-day attention rather than a routine appointment. A rapid, pounding or irregular heartbeat. Chest pain or breathlessness at rest. Marked tremor with agitation, confusion or a high fever. New or worsening double vision, loss of colour vision, or significant eye pain. Severe muscle weakness, or unexplained and rapid weight loss. These are reasons to seek urgent care, not to wait for the next lab draw.
Outside of those, the measured response to an unexpected thyroid result is to book an appointment, bring the full report rather than a single number, list every medicine and supplement you take, and describe the symptom timeline honestly, including the ones that seem unrelated. Discuss your results and any treatment with a clinician or licensed provider, who decides what testing and management are appropriate for you. Never ignore an abnormal result because you feel well, and never conclude a diagnosis from one line on a page.
If you want to see how the two directions of thyroid dysfunction separate on a report, the guide to hypothyroidism vs hyperthyroidism labs walks through both patterns side by side, and the question of whether pressure and poor sleep can tip thyroid results is covered in can stress cause hyperthyroidism.
A typical investigation starts with TSH, then adds free T4 and free T3 when TSH is suppressed. If the hormone pattern confirms an overactive thyroid, TSH receptor antibody testing follows to identify the cause. Thyroid peroxidase antibodies are sometimes added to round out the autoimmune picture, and your clinician decides which tests apply to you.
No. A low TSH tells you the pituitary has reduced its signal, which can happen for several reasons, including recent illness, thyroid inflammation and some medicines. Free T4, free T3 and antibody testing are what turn that signal into an interpretable picture. Only a clinician who has examined you can reach a diagnosis.
Fasting is generally not required for thyroid markers themselves. If the thyroid tests are part of a wider panel that includes glucose, insulin or lipids, follow the fasting instruction given for the full panel. Where possible, book a similar time of day for repeat draws so results stay comparable.
That combination is described as a subclinical pattern, meaning the pituitary has detected extra thyroid activity while the hormones still sit inside the reference range. It can be early, transient, or related to recovery from an illness. The usual next step is a repeat test rather than a conclusion, and your clinician sets the timing.
Yes. Antibody results and symptoms do not always move together, and a positive antibody value is interpreted alongside TSH, free T4 and free T3 rather than on its own. A borderline antibody result in particular needs the hormone pattern for context. Bring the whole report to your appointment, not one number.
Hormone levels show that the thyroid is overactive, but they do not identify why. TSH receptor antibody testing is the step that points toward an autoimmune, receptor-driven cause rather than an inflamed gland or an overactive nodule. Where the answer is still unclear, a clinician may add thyroid imaging.
Stress, poor sleep and acute illness can all shift thyroid markers temporarily, which is one reason a single abnormal result is usually repeated. Stress on its own does not explain a clearly suppressed TSH with raised free hormones. Mention anything unusual in the weeks before the draw when you discuss the result.
There is no single interval that fits everyone, because it depends on how far outside range the results were, whether symptoms are present, and what has already been ruled out. Your clinician sets the retest schedule. Using the same laboratory and a similar time of day makes the comparison more reliable.